Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: What is the mechanism?

Stem Cells and Development

Volumn 14, Issue 3, 2005, Pages 299-309

  Jaquet, Kai ^a   Krause, Korff T ^a   Denschel, Joachim ^a   Faessler, Patricia ^a   Nauerz, Mona ^a   Geidel, Stephan ^a   Boczor, Sigrid ^a   Lange, Claudia ^b   Stute, Norbert ^b   Zander, Axel ^b   Kuck, Karl Heinz ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CONTROLLED STUDY; FOLLOW UP; HEART MUSCLE CELL; HEART MUSCLE INJURY; IMMUNOHISTOCHEMISTRY; INJECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR;

ANIMALS; CELL DIFFERENTIATION; CICATRIX; DISEASE MODELS, ANIMAL; GENETIC MARKERS; HEART INJURIES; HUMANS; MESODERM; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TRANSFECTION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 21244458428     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2005.14.299     Document Type: Article

References (55)

1. Penn MS, M Zhang, I Deglurkar, and EJ Topol. (2004). Role of stem cell homing in myocardial regeneration. Int J Cardiol 95:23-25.
2. Taylor DA, BZ Atkins, P Hungspreugs, TR Jones, MC Reedy, KA Hutcheson, DD Glower and WE Kraus. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Med 4:929-933
3. Menasche P, AA Hagege, M Scorsin, B Pouzet, M Desnos, D Duboc, K Schwartz, JT Vilquin and JP Marolleau. (2001). Myoblast transplantation for heart failure. Lancet 357:279-280.
4. Orlic D, J Kajstura, S Chimenti, I Jakoniuk, SM Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, DM Bodine, A Led and P Anversa. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705.
5. Shake JG, PJ Gruber, WA Baumgartner, G Senechal, J Meyers, JM Redmond, MF Pittenger and BJ Martin. (2002). Mesenchymal stem cell implantation in a swine my-ocar-dial infarct model: engraftment and functional effects. Ann Thorac Surg 73:1919-1925.
6. Tomita S, DA Mickle, RD Weisel, ZQ Jia, LC Tumiati, Y Allidina, P Liu and RK Li. (2002). Improved heart function with myogenesis and angiogenesis after autologous por-cine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123:1132-1140.
7. Tse HF, YL Kwong, JK Chan, G Lo, CL Ho and CP Lau. (2003). Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361:47-49.
8. Forrester JS, MJ Price and RR Makkar. (2003). Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation 108:1139-1145.
9. Kocher AA, MD Schuster, MJ Szabolcs, S Takuma, D Burkhoff, J Wang, S Homma, NM Edwards and S Itescu. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med 7:430-446.
10. Orlic D, J Kajstura, S Chimenti, F Limana, I Jakoniuk, F Quaini, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98:10344-10349.
11. Wang JS, D Shum-Tim, J Galipeau, E Chedrawy, N Eliopoulos and RC Chiu. (2000). Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120:999-1005.
12. Hughes S. (2002). Cardiac stem cells. J Pathol 197:468-478.
13. Murry CE, MH Soonpaa, H Reinecke, H Nakajima, HO Nakajima, M Rubart, KB Pasumarthi, JI Virag, SH Bartelmez, V Poppa, G Bradford, JD Dowell, DA Williams and LJ Field. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668.
14. Balsam LB, AJ Wagers, JL Christensen, T Kofidis, IL Weissman and RC Robbins. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673.
15. Nygren JM, S Jovinge, M Breitbach, P Sawen, W Roll, J Hescheler, J Taneera, BK Fleischmann and SE Jacobsen. (2004). Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Med. 10:494-501.
16. Rasmusson I, O Ringden, B Sundberg and K Le Blanc. (2003) Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76:1208-1213.
17. Le Blanc K. (2003).Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5:485-489.
18. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
19. Li Z, M Schwieger, C Lange, J Kraunus, H Sun, E van den Akker, U Modlich, E Serinsoz, E Will, D von Laer, C Stocking, B Fehse, B Schiedlmeier and C Baum. (2003). Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. Exp Hematol 31:1206-1214.
20. Jaiswal N, SE Haynesworth, AI Caplan and SP Bruder. (1997). Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
21. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
22. Shakibaei M and P De Souza. (1997). Differentiation of mesenchymal limb bud cells to chondrocytes in alginate beads. Cell Biol Int 21:75-86.
23. Jackson KA, SM Majka, H Wang, J Pocius, CJ Hartley, MW Majesky, ML Entman, LH Michael, KK Hirschi and MA Goodell. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 107:1395-402.
24. Shintani S, T Murohara, H Ikeda, T Ueno, K Sasaki, J Duan and T Imaizumi. (2001) Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation. 103:897-903.
25. Orlic D, JM Hill and AE Arai. (2002). Stem cells for myocardial regeneration. Circ Res 91:1092-1102.
26. Orlic D. (2003). Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann N Y Acad Sci 996:152-157.
27. Orlic D. (2004). The strength of plasticity: stem cells for cardiac repair. Int J Cardiol. 95 (Suppl 1):S16-S19.
28. Castro RF, KA Jackson, MA Goodell, CS Robertson, H Liu and HD Shine. (2002). Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 297:1299.
29. Wagers AJ, RI Sherwood, JL Christensen and IL Weissman. (2002). Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256-2259.
30. Grigoriadis AE, JN Heersche and JE Aubin. (1988). Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol 106:2139-2151.
31. Haynesworth SE, J Goshima, VM Goldberg and AI Caplan. (1992). Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88.
32. Saito T, JE Dennis, DP Lennon, RG Young and AI Caplan. (1995). Myogenic expression of mesenchymal stem cells within myotubes of mdx mice in vitro and in vivo. Tissue Eng 1:327-343.
33. Wakitani S, T Saito and AI Caplan. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
34. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
35. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, H Abe, J Hata, A Umezawa and S Ogawa. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705.
36. Pittenger MF, JD Mosca and KR McIntosh. (2000). Human mesenchymal stem cells: Progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol 251: 3-11.
37. Toma C, MF Pittenger, KS Cahill, BJ Byrne and PD Kessler. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98.
38. Kawada H, J Fujita, K Kinjo, Y Matsuzaki, M Tsuma, H Miyatake, Y Muguruma, K Tsuboi, Y Itabashi, Y Ikeda, S Ogawa, H Okano, T Hotta, K Ando and K Fukuda. (2004). Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104:3581-3587.
39. Tomita S, RK Li, RD Weisel, DA Mickle, EJ Kim, T Sakai and ZQ Jia. (1999). Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-256.
40. Huwer H, J Winning, B Vollmar, C Welter, C Lohbach, MD Menger and HJ Schafers. (2003). Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats. Cell Transplant 12:757-767.
41. Pittenger MF and BJ Martin. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 95:9-20.
42. Fuchs S, R Baffour, YF Zhou, M Shou, A Pierre, FO Tio, NJ Weissman, MB Leon, SE Epstein and R Kornowski. (2001). Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37:1726-1732.
43. Yau TM, S Tomita, RD Weisel, ZQ Jia, LC Tumiati, DA Mickle and RK Li. (2003). Beneficial effect of autologous cell transplantation on infarcted heart function: com-pari-son between bone marrow stromal cells and heart cells. Ann Thorac Surg 75:169-176.
44. Heil M, T Ziegelhoeffer, B Mees and W Schaper. (2004). A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res 94:573-574.
45. Al-Khaldi A, H Al-Sabti, J Galipeau and K Lachapelle K. (2003) Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75:204-209.
46. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549.
47. Benjamin LE, D Golijanin, A Itin, D Pode and E Keshet. (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159-165.
48. Cotton JM, MR Thomas, BJ Dunmore, J Salisbury, AM Shah and NP Brindle. (2002). Angiogenesis in chronically ischaemic human heart following percutaneous myocardial revascularisation. Heart 87:281-283.
49. Ziegelhoeffer T, B Fernandez, S Kostin, M Heil, R Voswinckel, A Helisch and W Schaper. (2004). Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94:230-238.
50. Saito T, MP Pelletier, H Shennib and A Giaid. (2001). Nitric oxide system in needle-induced transmyocardial revascularization. Ann Thorac Surg 72:129-136.
51. Herzog EL, L Chai and DS Krause. (2003). Plasticity of marrow-derived stem cells. Blood 102:3483-3493.
52. Anderson DJ, FH Gage and IL Weissman. (2001 ). Can stem cells cross lineage boundaries? Nature Med 7:393-395.
53. Blau HM, TR Brazelton and JM Weimann. (2001). The evolving concept of a stem cell: entity or function? Cell 105:829-841.
54. Seale P, A Asakura and MA Rudnicki. (2001). The potential of muscle stem cells. Dev Cell 1:333-342.
55. Oh H, SB Bradfute, TD Gallardo, T Nakamura, V Gaussin, Y Mishina, J Pocius, LH Michael, RR Behringer, DJ Carry, ML Entman and MD Schneider. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100:12313-12318.